We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

179 hedge funds and large institutions have $854M invested in Viking Therapeutics in 2023 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 63 increasing their positions, 49 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

169% more call options, than puts

Call options by funds: $41.1M | Put options by funds: $15.3M

29% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 49

2.22% more ownership

Funds ownership: 74.91% → 77.13% (+2.2%)

7% less funds holding

Funds holding: 193 → 179 (-14)

28% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 43

30% less capital invested

Capital invested by funds: $1.21B → $854M (-$358M)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
179
Holders Change
-14
Holders Change %
-7.25%
% of All Funds
2.84%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
31
Increased
63
Reduced
49
Closed
43
Calls
$41.1M
Puts
$15.3M
Net Calls
+$25.9M
Net Calls Change
-$22.1M

Top Buyers

1
State Street
State Street
Massachusetts
+$22.8M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$21.5M
3
Viking Global Investors
Viking Global Investors
Connecticut
+$14.7M
4
American Century Companies
American Century Companies
Missouri
+$11.8M
5
AllianceBernstein
AllianceBernstein
Tennessee
+$8.42M

Top Sellers

1
Victory Capital Management
Victory Capital Management
Texas
-$11.2M
2
WA
Wasatch Advisors
Utah
-$10.7M
3
RI
RTW Investments
New York
-$10.6M
4
GPP
Great Point Partners
Connecticut
-$9.7M
5
PA
Perceptive Advisors
New York
-$6.31M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$166M +$408K +28,517 +0.2%
BlackRock
2
BlackRock
New York
$78.9M +$3.38M +235,994 +3%
State Street
3
State Street
Massachusetts
$71M +$22.8M +1,591,686 +33%
Vanguard Group
4
Vanguard Group
Pennsylvania
$58.5M +$2.46M +171,995 +3%
Viking Global Investors
5
Viking Global Investors
Connecticut
$50.6M +$14.7M +1,028,810 +29%
AllianceBernstein
6
AllianceBernstein
Tennessee
$39.3M +$8.42M +588,513 +20%
American Century Companies
7
American Century Companies
Missouri
$24.4M +$11.8M +822,156 +60%
Balyasny Asset Management
8
Balyasny Asset Management
Illinois
$23.5M +$21.5M +1,506,631 +245%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$22.4M +$2.58M +180,349 +10%
BC
10
Boxer Capital
California
$22.1M – – –
Millennium Management
11
Millennium Management
New York
$17.6M -$3.3M -230,426 -13%
DM
12
Deerfield Management
New York
$14.2M +$2.2M +154,000 +14%
WA
13
Wasatch Advisors
Utah
$10.7M -$10.7M -746,211 -44%
Northern Trust
14
Northern Trust
Illinois
$10.3M +$227K +15,874 +2%
Morgan Stanley
15
Morgan Stanley
New York
$9.86M -$6.15M -430,295 -33%
Invesco
16
Invesco
Georgia
$9.57M +$553K +38,695 +5%
IHAM
17
Integral Health Asset Management
New York
$8.86M +$1M +70,000 +10%
Charles Schwab
18
Charles Schwab
California
$8.47M +$7.23M +505,578 +195%
EAM
19
Eventide Asset Management
Massachusetts
$8.3M – – –
Bank of America
20
Bank of America
North Carolina
$7.66M +$4.11M +287,508 +71%
6CM
21
683 Capital Management
New York
$6.92M +$644K +45,000 +8%
Two Sigma Investments
22
Two Sigma Investments
New York
$6.84M +$2.85M +199,016 +47%
SCM
23
Sio Capital Management
New York
$6.59M +$963K +67,345 +13%
Goldman Sachs
24
Goldman Sachs
New York
$6.58M -$1.41M -98,273 -14%
5VM
25
5AM Venture Management
California
$6.48M – – –
1
2 3 4 5

VKTX Hedge Fund Activity: Q3 2023 in Review

179 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q3 2023, worth a combined $854M — down 30% from $1.21B a quarter earlier.

Sellers outnumbered buyers: 43 funds closed out of VKTX and 31 opened new positions — a net loss of 12 holders — while 49 trimmed existing stakes and 63 added.

The largest buyer was State Street, adding an estimated $22.8M. The largest seller was Victory Capital Management, cutting an estimated $11.2M.

  • 179 institutional investors held Viking Therapeutics (VKTX) as of Q3 2023, down from 193 in Q2 2023.
  • Funds reported $854M of Viking Therapeutics stock for Q3 2023, down 30% quarter-over-quarter.
  • 31 funds opened new Viking Therapeutics positions in Q3 2023 and 43 closed out, a net change of -12 holders.
  • The largest Viking Therapeutics buyer in Q3 2023 was State Street, an estimated $22.8M added.
  • The largest Viking Therapeutics seller in Q3 2023 was Victory Capital Management, an estimated $11.2M sold.

Based on aggregated 13F filings for Q3 2023.